17-39665874-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong
The NM_003673.4(TCAP):c.269C>T(p.Pro90Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,611,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P90P) has been classified as Benign.
Frequency
Consequence
NM_003673.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000410 AC: 1AN: 243776Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 132970
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1459194Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 725840
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2011 | The Pro90Leu variant has been reported in one individual with HCM and was absent from 400 control chromosomes (200 White, 200 Black; Bos 2006). Of note, this i ndividual also carried a MYBPC3 variant of possible significance (Gln998Arg). O ur laboratory has detected the Pro90Leu variant in 1 Caucasian DCM proband (out of >336 Caucasian probands tested). Proline (Pro) at position 90 is conserved a cross evolutionary distant species, suggesting that a change would not be tolera ted. However it is not conserved in a single mammalian species (chimp has an al anine), making it difficult to interpret this data. Three computer tools (Polyp hen2, SIFT, MAPP) predict this change to be deleterious; however, their accuracy is unknown. In summary, additional data (functional/segregation/control studies ) is needed to determine the clinical significance of this variant. - |
TCAP-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 12, 2024 | The TCAP c.269C>T variant is predicted to result in the amino acid substitution p.Pro90Leu. This variant has been reported in one patient with hypertrophic cardiomyopathy (HCM), who was also heterozygous for a missense variant in a different HCM-related gene (Bos et al. 2006. PubMed ID: 16352453). This variant was also found in a patient with dilated cardiomyopathy (DCM) and was reported as a variant of uncertain significance (Table S1B, Walsh et al. 2017. PubMed ID: 27532257). This variant is reported in 0.0016% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 21, 2020 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2024 | The p.P90L variant (also known as c.269C>T), located in coding exon 2 of the TCAP gene, results from a C to T substitution at nucleotide position 269. The proline at codon 90 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 177970). This missense change has been observed in individual(s) with either hypertrophic cardiomyopathy (HCM) and/or dilated cardiomyopathy (DCM) (PMID: 16352453, 27532257). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 90 of the TCAP protein (p.Pro90Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at